These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31807947)

  • 21. Immunological evaluation of colonic delivered Hepatitis B surface antigen loaded TLR-4 agonist modified solid fat nanoparticles.
    Sahu KK; Pandey RS
    Int Immunopharmacol; 2016 Oct; 39():343-352. PubMed ID: 27526270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
    Mishra D; Mishra PK; Dubey V; Nahar M; Dabadghao S; Jain NK
    Eur J Pharm Sci; 2008 Apr; 33(4-5):424-33. PubMed ID: 18359615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B.
    Mishra N; Tiwari S; Vaidya B; Agrawal GP; Vyas SP
    J Drug Target; 2011 Jan; 19(1):67-78. PubMed ID: 20334603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
    Saini V; Jain V; Sudheesh MS; Jaganathan KS; Murthy PK; Kohli DV
    Int J Pharm; 2011 Apr; 408(1-2):50-7. PubMed ID: 21291968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single dose HBsAg CS-γ-PGA nanogels induce potent protective immune responses against HBV infection.
    Wang H; Han Q; Zhao H; Xu D; Zhang J
    Eur J Pharm Biopharm; 2018 Mar; 124():82-88. PubMed ID: 29247691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
    Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
    Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles.
    Kabiri M; Sankian M; Sadri K; Tafaghodi M
    Eur J Pharm Biopharm; 2018 Dec; 133():321-330. PubMed ID: 30408519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
    Li Z; Xiong F; He J; Dai X; Wang G
    Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
    Pawar D; Jaganathan KS
    Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential Hepatitis B Vaccine Formulation Prepared by Uniform-Sized Lipid Hybrid PLA Microparticles with Adsorbed Hepatitis B Surface Antigen.
    Liu Q; Chen X; Jia J; Lu T; Yang T; Wang L
    Mol Pharm; 2018 Nov; 15(11):5227-5235. PubMed ID: 30350642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mannosylated polylactic-co-glycolic acid (MN-PLGA) nanoparticles induce potent anti-tumor immunity in murine model of breast cancer.
    Sheikhzadeh S; Delirezh N; Hobbenaghi R
    Biomed Pharmacother; 2021 Oct; 142():111962. PubMed ID: 34358752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodegradable polylactide microspheres enhance specific immune response induced by Hepatitis B surface antigen.
    Qiu S; Wei Q; Liang Z; Ma G; Wang L; An W; Ma X; Fang X; He P; Li H; Hu Z
    Hum Vaccin Immunother; 2014; 10(8):2350-6. PubMed ID: 25424942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant to enhance immune responses.
    Gu P; Wusiman A; Wang S; Zhang Y; Liu Z; Hu Y; Liu J; Wang D
    Carbohydr Polym; 2019 Nov; 223():115128. PubMed ID: 31427012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.
    Jain S; Singh P; Mishra V; Vyas SP
    Immunol Lett; 2005 Oct; 101(1):41-9. PubMed ID: 15869802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted novel surface-modified nanoparticles for interferon delivery for the treatment of hepatitis B.
    Giri N; Tomar P; Karwasara VS; Pandey RS; Dixit VK
    Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):877-83. PubMed ID: 21914636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly(Lactide-
    Mohammed MM; Naif HM
    Viral Immunol; 2022 Mar; 35(2):112-121. PubMed ID: 35020522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
    Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J
    J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted Delivery of GP5 Antigen of PRRSV to M Cells Enhances the Antigen-Specific Systemic and Mucosal Immune Responses.
    Du L; Yu Z; Pang F; Xu X; Mao A; Yuan W; He K; Li B
    Front Cell Infect Microbiol; 2018; 8():7. PubMed ID: 29423381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.